These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 26077324)

  • 41. Upper limb function is normal in patients with restless legs syndrome (Willis-Ekbom Disease).
    Todd G; Haberfield M; Faulkner PL; Hayes M; Wilcox RA; Rae C; Bulathsinhala T; Grunstein RR; Yee BJ; Double KL
    Clin Neurophysiol; 2015 Apr; 126(4):736-42. PubMed ID: 25113274
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Long-Term Treatment of Restless Legs Syndrome (RLS): An Approach to Management of Worsening Symptoms, Loss of Efficacy, and Augmentation.
    Mackie S; Winkelman JW
    CNS Drugs; 2015 May; 29(5):351-7. PubMed ID: 26045290
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Augmentation as a treatment complication of restless legs syndrome: concept and management.
    García-Borreguero D; Allen RP; Benes H; Earley C; Happe S; Högl B; Kohnen R; Paulus W; Rye D; Winkelmann J
    Mov Disord; 2007; 22 Suppl 18():S476-84. PubMed ID: 17580331
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Review of quality of life instruments for the restless legs syndrome/Willis-Ekbom Disease (RLS/WED): critique and recommendations.
    Walters AS; Frauscher B; Allen R; Benes H; Chaudhuri KR; Garcia-Borreguero D; Lee HB; Picchietti DL; Trenkwalder C; Martinez-Martin P; Stebbins GT; Schrag A;
    J Clin Sleep Med; 2014 Dec; 10(12):1351-7. PubMed ID: 25348243
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Effect of Cannabidiol for Restless Legs Syndrome/Willis-Ekbom Disease in Parkinson's Disease Patients with REM Sleep Behavior Disorder: A
    de Almeida CMO; Brito MMC; Bosaipo NB; Pimentel AV; Sobreira-Neto MA; Tumas V; Zuardi AW; Crippa JAS; Hallak JEC; Eckeli AL
    Cannabis Cannabinoid Res; 2023 Apr; 8(2):374-378. PubMed ID: 35749710
    [No Abstract]   [Full Text] [Related]  

  • 46. Diagnosis of Restless Leg Syndrome (Willis-Ekbom Disease).
    Becker PM
    Sleep Med Clin; 2015 Sep; 10(3):235-40, xii. PubMed ID: 26329433
    [TBL] [Abstract][Full Text] [Related]  

  • 47. F-Wave Duration as a Specific and Sensitive Tool for the Diagnosis of Restless Legs Syndrome/Willis-Ekbom Disease.
    Congiu P; Fantini ML; Milioli G; Tacconi P; Figorilli M; Gioi G; Pereira B; Marrosu F; Parrino L; Puligheddu M
    J Clin Sleep Med; 2017 Mar; 13(3):369-375. PubMed ID: 28095964
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Reduced response to gabapentin enacarbil in restless legs syndrome following long-term dopaminergic treatment.
    Garcia-Borreguero D; Cano-Pumarega I; Garcia Malo C; Cruz Velarde JA; Granizo JJ; Wanner V
    Sleep Med; 2019 Mar; 55():74-80. PubMed ID: 30772697
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Short-interval intracortical inhibition is decreased in restless legs syndrome across a range of severity.
    Magalhães SC; Queiroz de Paiva JP; Kaelin-Lang A; Sterr A; Eckeli AL; Winkler AM; Fernandes do Prado G; Amaro E; Conforto AB
    Sleep Med; 2019 Oct; 62():34-42. PubMed ID: 31539846
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacologic Treatment of Restless Legs Syndrome.
    Lv Q; Wang X; Asakawa T; Wang XP
    Curr Neuropharmacol; 2021; 19(3):372-382. PubMed ID: 33380302
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Willis-Ekbom disease is not associated with poor cardiovascular health in adults.
    Dredla BK; Del Brutto OH; Lee AS; Castillo PR
    J Negat Results Biomed; 2015 Nov; 14():17. PubMed ID: 26545868
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Restless Legs Syndrome/Willis-Ekbom Disease and Periodic Limb Movements in Sleep in the Elderly with and without Dementia.
    Figorilli M; Puligheddu M; Ferri R
    Sleep Med Clin; 2015 Sep; 10(3):331-42, xiv-xv. PubMed ID: 26329443
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Long-term treatment of restless legs syndrome with dopamine agonists.
    Ondo W; Romanyshyn J; Vuong KD; Lai D
    Arch Neurol; 2004 Sep; 61(9):1393-7. PubMed ID: 15364685
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Sensorimotor white matter projections and disease severity in primary Restless Legs Syndrome/Willis-Ekbom disease: a multimodal DTI analysis.
    de Paiva JPQ; Magalhães SC; Moura LM; Sato JR; Amaro E; Sterr A; Schlaffke L; Eckeli AL; do Prado GF; Conforto AB
    Sleep Med; 2020 Sep; 73():106-116. PubMed ID: 32805477
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Transcranial magnetic stimulation for evaluation of motor cortical excitability in restless legs syndrome/Willis-Ekbom disease.
    Magalhães SC; Kaelin-Lang A; Sterr A; do Prado GF; Eckeli AL; Conforto AB
    Sleep Med; 2015 Oct; 16(10):1265-73. PubMed ID: 26429756
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Restless legs syndrome: pathophysiology and modern management.
    Nagandla K; De S
    Postgrad Med J; 2013 Jul; 89(1053):402-10. PubMed ID: 23524988
    [TBL] [Abstract][Full Text] [Related]  

  • 57. French consensus: Pharmacoresistant restless legs syndrome.
    Chenini S; Arnulf I; Monaca CC; Ghorayeb I
    Rev Neurol (Paris); 2018; 174(7-8):522-531. PubMed ID: 30075957
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Restless legs syndrome: a review of diagnosis and management in primary care.
    Bogan RK; Cheray JA
    Postgrad Med; 2013 May; 125(3):99-111. PubMed ID: 23748511
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Which Factors in Spinocerebellar Ataxia Type 3 Patients Are Associated with Restless Legs Syndrome/Willis-Ekbom Disease?
    Gitaí LLG; Éckeli AL; Sobreira-Neto MA; Diniz PRB; Santos AC; Júnior WM; Fernandes RMF
    Cerebellum; 2021 Feb; 20(1):21-30. PubMed ID: 32946033
    [TBL] [Abstract][Full Text] [Related]  

  • 60. EFNS guidelines on management of restless legs syndrome and periodic limb movement disorder in sleep.
    Vignatelli L; Billiard M; Clarenbach P; Garcia-Borreguero D; Kaynak D; Liesiene V; Trenkwalder C; Montagna P;
    Eur J Neurol; 2006 Oct; 13(10):1049-65. PubMed ID: 16987157
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.